Korea Bio-Gen Co.Ltd (318000) — Cash Flow Quality Index
Korea Bio-Gen Co.Ltd (318000) has a Cash Flow Quality Index of 0.19x as of March 2026. Operating cash flow of ₩145.77 Million is below net income of ₩762.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 318000 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Korea Bio-Gen Co.Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Korea Bio-Gen Co.Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 318000 operating cash flow.
Annual Cash Flow Quality Index for Korea Bio-Gen Co.Ltd (2017–2025)
Year-by-year earnings quality comparison for Korea Bio-Gen Co.Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.83x | ₩7.34 Billion | ₩2.59 Billion | ▲ +148.6% |
| 2024 | 1.14x | ₩4.29 Billion | ₩3.77 Billion | ▼ -44.9% |
| 2023 | 2.07x | ₩9.47 Billion | ₩4.58 Billion | ▲ +302.4% |
| 2022 | 0.51x | ₩1.67 Billion | ₩3.25 Billion | ▼ -33.6% |
| 2021 | 0.77x | ₩3.09 Billion | ₩4.00 Billion | ▼ -6.5% |
| 2020 | 0.83x | ₩2.58 Billion | ₩3.12 Billion | ▲ +6.6% |
| 2018 | 0.78x | ₩1.98 Billion | ₩2.56 Billion | ▲ +3.7% |
| 2017 | 0.75x | ₩1.38 Billion | ₩1.85 Billion | — |